QH103 Cell Injection for the Treatment of Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia
Clinical trial NCT06056752 · UNKNOWN
Trial details
- NCT number
- NCT06056752
- Sponsor
- Anhui Provincial Hospital
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-27
- Primary completion
- 2025-07-03
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.